Equities

Lipidor AB

Lipidor AB

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (SEK)10.80
  • Today's Change-0.06 / -0.55%
  • Shares traded21.43k
  • 1 Year change-13.94%
  • Beta--
Data delayed at least 15 minutes, as of Sep 17 2021 17:00 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Lipidor AB is a Sweden-based drug delivery company focusing on topical medication. The Company is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The Company develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Company’s cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.

  • Revenue in SEK (TTM)730.00k
  • Net income in SEK-17.69m
  • Incorporated--
  • Employees--
  • Location
    Lipidor ABKarolinska Institutet Science ParkFogdevreten 2SOLNA 171 65SwedenSWE
  • Websitehttp://www.lipidor.se/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fluicell AB3.98m-19.25m257.81m----18.20--64.73-1.73-1.730.35861.180.20760.6145.30---100.35-86.20-187.17-114.5377.35---483.33-526.302.08-29.460.00--86.29--5.61------
Spago Nanomedical AB (publ)342.00k-19.94m283.33m----1.30--828.46-0.6501-0.65010.01115.290.0019--22.06---11.16-11.65-11.40-11.991,634.2116,906.08-5,830.70-14,093.92----0.00--1,040.00--6.35------
Moberg Pharma AB (publ)-100.00bn-100.00bn284.45m12.00--0.6241----------10.01----------------------------0.0136--------------
SenzaGen AB9.14m-28.18m294.74m16.00--3.14--32.24-1.32-1.320.42814.400.08182.644.96---25.20-25.24-26.11-26.8162.08207.96-308.21-805.8820.19-1,760.250.00--192.1435.4145.92---33.21--
Coegin Pharma AB-4.09k-60.74m303.85m----10.05-----0.3717-0.3717-0.000010.0494-0.0002-------215.39---320.97-------------9,640.770.00---100.00---73.39------
Lipidor AB730.00k-17.69m308.39m----5.21--422.45-0.6838-0.68380.02832.090.017--3.45---41.10---42.55-------2,423.01------0.00--761.11---17.36------
Active Biotech AB publ6.23m-34.65m311.70m11.00--4.22--50.07-0.1778-0.17780.03260.3390.0981--1.92---54.60-20.47-63.39-33.08-----556.55-364.66----0.0014---20.18-16.205.53------
Herantis Pharma Oyj0.00-128.03m320.72m-----------1.20-1.200.00-0.0360.00-------121.29-50.54-173.91-58.09-------110,423.80---17.321.05-------14.35------
Dextech Medical AB0.00-6.08m320.79m1.00--45.72-----0.4072-0.40720.000.47020.00-------59.04-38.33-60.43-39.99--------------------21.24------
RLS Global AB1.23m-10.63m326.25m----10.03--264.60-0.1594-0.15940.01850.48740.0292--0.135---25.16-54.63-28.10-66.50--49.32-862.29-958.264.92--0.00--99.71-0.648116.93---35.72--
RhoVac AB9.60m-43.74m334.09m----4.30--34.79-2.30-2.300.50414.080.0874--0.8516---39.81-42.16-43.48-46.72-----455.58-950.54---209.610.00--0.558---16.51------
Cyxone AB-100.00bn-100.00bn343.22m6.00--5.35----------1.01----------------------------0.00-------39.34------
Bactiquant A/S9.13m-6.56m343.58m----8.44--37.62-0.2607-0.26070.36291.620.28823.247.32---20.7113.96-22.7416.285.73---71.8539.469.35-73.840.00---64.62---135.01------
Aqua Bio Technology ASA777.04k-17.67m354.22m2.00--24.24--455.86-0.9844-0.98440.04330.74260.04720.62480.4401---107.32-42.18-184.80-51.66-79.99-72.16-2,274.58-2,362.501.05-35.650.3348---50.152.97-11.26---41.51--
Corline Biomedical AB5.76m-5.76m359.97m8.00--3.77--62.45-0.3104-0.31040.31584.450.0717--13.01720,500.00-7.17-14.05-7.69-15.57160.53406.13-99.98-463.81---479.250.00--247.3728.9423.62--12.68--
Alligator Bioscience AB4.39m-133.06m363.65m45.00--2.97--82.76-1.67-1.670.05491.430.0233--0.8717102,186.00-70.48-25.15-84.71-26.86-----3,028.31-408.24---183.040.0645---0.1377-56.8231.80---44.99--
Data as of Sep 17 2021. Currency figures normalised to Lipidor AB's reporting currency: Swedish Krona SEK
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image